Macrogenics Inc

Research Macrogenics Inc (MGNX) on Bullrun: market cap USD 308.92M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerMGNX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 308.92M
• Financial periodFY2025
• RevenueUSD 149.50M
• Revenue growth-0.3%
• Net income-USD 74.62K
• Free cash flow-USD 82.95M
• Gross margin100.0%

Valuation Snapshot

latest market cap is USD 308.92M.

About Macrogenics Inc

MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics for the treatment of cancer in the United States.

Frequently asked questions

What is Macrogenics Inc's market cap?

Macrogenics Inc's market capitalization is USD 308.92M.

What does Macrogenics Inc do?

MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics for the treatment of cancer in the United States.